ASLAN Pharmaceuticals Limited IPO Research Information

ASLAN Pharmaceuticals Limited IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on ASLAN Pharmaceuticals Limited, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
ASLAN Pharmaceuticals Limited	ASLN - NASDAQ	$8.05-$8.05	$7.03	$6.15	6 million ADSs	5/4/2018
Underwriter(s): Leerink Partners, Piper Jaffray
Co-Manager(s): BTIG, H.C. Wainwright & Co., CLSA
Industry: Health Care
Filing(s): Filed 2018-03-26 Terms Added 2018-04-16 Final Prospectus 2018-05-07

ASLAN Pharmaceuticals Limited Quote & Chart - Click for current quote - ASLN

About ASLAN Pharmaceuticals Limited (adapted from ASLAN Pharmaceuticals Limited prospectus):
They are a clinical-stage oncology-focused biopharmaceutical company based in Singapore developing novel therapeutics for global markets. We target diseases that are both highly prevalent in Asia and orphan indications in the United States and Europe.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ASLN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.